AnakinraToxidermia follwing off-label treatment: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1751卷 / 1期

关键词：

D O I：

10.1007/s40278-019-61168-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：35 / 35

相关论文

共 50 条

[41] IbrutinibNeutropenia and off-label use: case report
Reactions Weekly, 2020, 1787 (1) : 271 - 271
[42] RituximabLack of efficacy and off-label: case report
Reactions Weekly, 2022, 1932 (1) : 522 - 522
[43] DexmedetomidineHypotension and off-label use: case report
Reactions Weekly, 2019, 1749 (1) : 172 - 172
[44] AzithromycinCardiotoxicity and Off-label use: case report
Reactions Weekly, 2023, 1953 (1) : 100 - 100
[45] AntineoplasticsPancytopenia and off-label use: case report
Reactions Weekly, 2020, 1825 (1) : 39 - 39
[46] RituximabCellulitis and off-label use: case report
Reactions Weekly, 2022, 1911 (1) : 363 - 363
[47] Amantadine overdoseVarious toxicities secondary to off-label treatment: case report
Reactions Weekly, 2018, 1712 (1) : 46 - 46
[48] RanibizumabRespiratory complication following off-label treatment with ranibizumab: case report
Reactions Weekly, 2018, 1717 (1) : 242 - 242
[49] Dabrafenib/trametinibNausea and vomiting following off-label treatment: case report
Reactions Weekly, 2020, 1830 (1) : 129 - 129
[50] Case Report: Off-label treatment of idiopathic hypereosinophilic syndrome with Omalizumab
Zhang, Zhiyu
Sun, Yingxin
Chen, Su-Ning
FRONTIERS IN PHARMACOLOGY, 2023, 14

← 1 2 3 4 5 →